University of Missouri researchers have released the world's largest collection of protein models with quality assessment—a groundbreaking new resource that could accelerate drug development for ...
A new artificial intelligence-driven pipeline developed in a collaborative research combines protein structure prediction, ...
A classic Swiss pair remains the standard-bearer.
AI must not deepen inequality. The focus shifted to access—compute, skills, trust—and multilingual, real-world outcomes.
HYDERABAD: The opening day of BioAsia 2026 highlighted the transformative role of artificial intelligence in science and healthcare, alongside deliberations on ...
Soy Carmín on MSN
Toxic Leftovers? 6 Foods You Should NEVER Reheat
Look, we’ve all been there—staring at last night’s leftovers and thinking, "I’ll just pop this in the microwave for two minutes." But honestly, some of these staples we take for granted can actually ...
Proteins often function in pairs or groups, concealing their internal connection points and making it difficult for scientists to study their individual units without altering their natural structure.
News: BioAI at India AI Impact Summit outlined how AI+biology can accelerate biomanufacturing—using genomics, in-silico design, and data loops for scale and trust.
Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.
Age-related changes in protein tagging and degradation may help explain how the brain declines over time and why diet can still influence these processes.
News Medical on MSN
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results